α4β2 Nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder

Journal of Pharmacology and Experimental Therapeutics

Volumn 302, Issue 1, 2002, Pages 95-100

  Ueno, Ken Ichi ^a   Togashi, Hiroko ^a   Matsumoto, Machiko ^a   Ohashi, Satoshi ^a   Saito, Hideya ^b   Yoshioka, Mitsuhiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Department of Health Sciences   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4BETA2 NICOTINIC RECEPTOR; DIHYDRO BETA ERYTHROIDINE; HEXAMETHONIUM; MECAMYLAMINE; METHYLLYCACONITINE; METHYLPHENIDATE; N METHYL 4 (3 PYRIDINYL) 3 BUTENAMINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; ALPHA-BUNGAROTOXIN RECEPTOR; BUNGAROTOXIN RECEPTOR; CENTRAL NERVOUS SYSTEM AGENTS; NICOTINIC RECEPTOR ALPHA4BETA2;

ADOLESCENT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; WORKING MEMORY; ANIMAL; GENETICS; HYPERTENSION; PERIPHERAL NERVOUS SYSTEM; PSYCHOLOGICAL ASPECT; WISTAR KYOTO RAT;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM AGENTS; DIHYDRO-BETA-ERYTHROIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEXAMETHONIUM; HYPERTENSION; MECAMYLAMINE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PERIPHERAL NERVOUS SYSTEM; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, NICOTINIC;

EID: 0035983542     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.302.1.95     Document Type: Article

References (40)

1. Ventral hippocampal α4β2 nicotinic receptors and chronic nicotine effects on memory
2. A review of stimulant drug research with hyperactive children
3. Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: Antagonist studies
4. Nicotine and attention in adult ADHD
5. Nicotinic receptor function: New perspectives from knockout mice
6. Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats
7. Changes in nicotinic acetylcholine receptor subunit mRNA and nicotinic binding in spontaneously hypertensive stroke prone rats
8. Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task
9. A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus
10. Dysfunction of choline transport system through blood-brain barrier in stroke-prone spontaneously hypertensive rats
11. Dopaminergic involvement in attention: A novel animal model
12. Nicotine systems and cognitive function
13. AR-R17779, an α7 nicotinic agonist, improves learning and memory in rats
14. Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder
15. Nicotine effects on adults with attention-deficit/hyperactivity disorder
16. Development of nicotinic drug therapy for cognitive disorders
17. Nicotinic acetylcholine involvement in cognitive function in animals
18. Nicotine effects and attention deficit disorder
19. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits
20. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: Comparison of naive and chronic nicotine-treated rats
21. ADHD is associated with early initiation of cigarette smoking in children and adolescents
22. Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats
23. Activation of the reticulothalamic cholinergic pathway by major metabolites of aniracetam
24. Site-specific activation of dopamine and serotonin transmission by aniracetam in the mesocorticolimbic pathway of rats
25. Transdermal nicotine: Reduction of smoking with minimal abuse liability
26. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder
27. Cognitive effects of nicotine
28. The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): Changed reactivity to reinforcers and to psychomotor stimulants
29. Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rats strains
30. Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and agonist β-carbolines
31. Group II metabotropic glutamate receptors are a common target of N-anisoyl-GABA and 1S,3R-ACPD in enhancing ACh release in the prefrontal cortex of freely moving SHRSP
32. A microdialysis study of the effects of the nicotinic agonist RJR-2403 on cortical release of acetylcholine and biogenic amines
33. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain - An in vivo microdialysis study
34. Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats
35. Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats
36. Behavioral and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder
37. Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults
38. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder
39. The spontaneously hypertensive rat as an animal model attention-deficit hyperactivity disorder: Effects of methylphenidate on exploratory behavior
40. Brain nicotine cholinoceptor binding in spontaneous hypertension